Conference Reports for NATAP

AASLD The Liver Meeting Boston MA November 2016 Back

Risk of Incident Liver Cancer Following HCV Treatment With Sofosbuvir-Containing Regimens       AP. Chokkalingam, AW. Singer, A Osinusi, DM. Brainard, LE. Telep Gilead Sciences, CA USA